Extra-tumoral breast tissue in breast-cancer patients: Variations with a family history of breast cancer

International Journal of Cancer

Volumn 79, Issue 1, 1998, Pages 39-43

  Aaman, Tone B ^a   Stalsberg, Helge ^a   Thomas, David B ^b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; BREAST CYST; BREAST DUCT ECTASIA; BREAST HYPERPLASIA; BREAST LESION; CANCER RISK; FAMILY HISTORY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; METAPLASIA; PREVALENCE; PRIORITY JOURNAL;

BREAST DISEASES; BREAST NEOPLASMS; FEMALE; FIBROCYSTIC BREAST DISEASE; HUMANS; ODDS RATIO;

EID: 0032548956     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980220)79:1<39::AID-IJC8>3.0.CO;2-X     Document Type: Article

References (23)

1. AAMAN, T.B., STALSBERG, H., THOMAS, D.B. and THE WHO COLLABORATIVE STUDY OF NEOPLASIA AND STEROID CONTRACEPTIVES, The extra-tumoral breast tissue of breast-cancer patients: variation with age and country of residence in low- and high-risk countries. Int. J. Cancer, 71, 333-339 (1997).
2. BERKOWITZ, G.S., KELSEY, J.L., LIVOLSI, V.A., HOLFORD, T.R., MERINO, M.J., ORT, S., O'CONNOR, T.Z. and WHITE, C. Risk factors for fibrocystic breast disease and its histopathologic components. J. nat. Cancer Inst., 75, 43-50 (1985).
3. BREAST-CANCER-LINKAGE CONSORTIUM, Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet, 349, 1505-1510 (1997).
4. CARTER, C.L., CORLE, D.K., MICOZZI, M.S., SCHATZKIN, A. and TAYLOR, P.R., A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Amer. J. Epidemiol., 128, 467-477 (1988).
5. CISKE, D.J., RICH, S.S., KING, R.A., ANDERSON, V.E., BARTOW, S., VACHON, C., MCGOVERN, P.G., KUSHI, L.H., ZHENG, W. and SELLERS, T.A., Segregation analysis of breast cancer: a comparison of type-dependent age-at-onset versus type-dependent susceptibility models. Genet. Epidemiol., 13, 317-328 (1996).
6. COHEN, P., A positive family history of breast cancer and benign breast disease: does its effect diminish with age? Arch. intern. Med., 151, 402-404 (1991).
7. COLDITZ, G.A., WILLETT, W.C., HUNTER, D.J., STAMPFER, M.J., MANSON, J.E., HENNEKENS, C.H., ROSNER, B.A. and SPEIZER, F.E., Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study. J. Amer. med. Ass., 270, 338-343 (1993).
8. COOK, M.G. and ROMAN, I.E., Benign breast disease: the relationship between its histological features and risk factors for breast cancer. Pathology, 23, 286-290 (1991).
9. CORNELISSE, C.J., CORNELIS, R.S. and DEVILEE, P., Genes responsible for familial breast cancer. Pathol. Res. Pract., 192, 684-693 (1996).
10. DUPONT, W.D. and PAGE, D.L., Risk factors for breast cancer in women with proliterative breast disease. New Engl. J. Med., 312, 146-151 (1985).
11. FITZGERALD, M.G. and 18 OTHERS, Germ-line BRCAI mutations in Jewish and non-Jewish women with early-onset breast cancer. New Engl. J. Med., 334, 143-149 (1996).
12. HULKA, B.S. and STARK, A.T., Breast cancer: cause and prevention. Lancet, 346, 883-887 (1995).
13. MUTTER, R.V.P., Is "fibrocystic disease" of the breast pre-cancerous? Arch. Pathol. Lab. Med., 110, 171-173 (1986).
14. JENSEN, R.A., PAGE, D.L., DUPONT, W.D. and ROGERS, L.W., Invasive-breast-cancer risk in women with sclerosing adenosis. Cancer, 64, 1977-1983 (1989).
15. KLIEWER, E.V. and SMITH, K.R., Breast-cancer mortality among immigrants in Australia and Canada. J. nat. Cancer Inst., 87, 1154-1161 (1995).
16. MARIUZZI, G.M., MARIUZZI, L., MOMBELLO, A., SANTINELLI, A., VALLI, M., RAHAL, D., THOMPSON, D. and BARTELS, PH., Quantitative study of ductal-breast-cancer progression. A progression index (P.I.) for premalignant lesions and in situ carcinoma. Pathol. Res. Pract, 192, 428-436 (1996).
17. PAGE, D.L. and DUPONT, W.D., Anatomic markers of human premalignancy and risk of breast cancer. Cancer, 66, 1326-35 (1990).
18. ROSEMAN, D.L., STRAUS, A.K. and SHOREY, W., A positive family history of breast cancer. Does its effect diminish with age? Arch. intern. Med., 150, 191-194 (1990).
19. SAS, SAS language and procedures: usage, version 6 (1st ed.), SAS Institute, Cary, NC (1989).
20. SZABO, C.I. and KING, M.-C., Inherited breast and ovarian cancer. Hum. mol. Genet., 4, 1811-1817 (1995).
21. SKOLNICK, M.H. and 12 OTHERS, Inheritance of proliferative breast disease in breast-cancer kindreds. Science, 250, 1715-1720 (1990).
22. STALSBERG, H., THOMAS, D.B., NOONAN, E.A. and THE WHO COLLABORATIVE STUDY OF NEOPLASIA AND STEROID CONTRACEPTIVES, Histologic types of breast carcinoma in relation to international variation and breast-cancer-risk factors. Int. J. Cancer, 44, 399-409 (1989).
23. WHO COLLABORATIVE STUDY OF NEOPLASIA AND STEROID CONTRACEPTIVES, Breast cancer and combined oral contraceptives: results from a multinational study. Brit. J. Cancer. 61, 110-119 (1990).